Dividends & Income
To screen ETFs by asset class, performance, yield and more, check out the
As far as
, they have a huge problem with Jakafi. For details, look at youtube video by Dr. Pardanani, who is @ Mayo.
Jakafi is a terrible drug for MF and should not have been approved by the FDA. This makes other indications for Jakafi very questionable.
Add a reply...
Latest StockTalks »
people get INCY breaking news and analysis by email alert.
Get email alerts on INCY »
Get latest price
From other sites
Earnings Estimates Moving Higher for Incyte (INCY): Time to Buy? - Tale of the Tape
at Zacks.com (Wed, 8:39AM)
INCYTE : Change in Directors or Principal Officers (form 8-K)
at 4-traders.com (May 4, 2015)
Incyte Posts Wider-than-Expected Q1 Loss, Jakafi Grows - Analyst Blog
at Zacks.com (May 4, 2015)
Commit To Purchase Incyte Corporation At $67.50, Earn 7% Annualized Using Options
at Nasdaq.com (Mar 11, 2015)
10 Biotech Stories You Might've Missed This Week
at Benzinga.com (Jan 15, 2015)
Xignite quote data
© 2015 Seeking Alpha